Human Colon Cancer Tissue Lysates

Pricing
Normal Lysates:  $125/100 ug
Tumor Lysates:   $175/100 ug
Nor./Tum. set: $270.00 (10% off)
Discounts
2-8    Vials  10%
9-20  Vials  15%
>20   Vials  20%

Introduction:

Histologic types of colon cancer include the following:

Adenocarcinoma (most colon cancers); Mucinous (colloid) adenocarcinoma, Signet ring adenocarcinoma.

Scirrhous tumors.

Neuroendocrine. Tumors with neuroendocrine differentiation typically have a poorer prognosis than pure adenocarcinoma variants.

Human Colon Cancer Tissue Lysates

Catalog Number

Diagnosis

Grade

Stage

TNM

Sex

Age

T7-001

Adenocarcinoma

2

n/a

n/a

F

70

T7-002

Adenocarcinoma

2

I

T2N0M0

M

77

T7-003

Adenocarcinoma

1

I

T2N0M0

M

75

T7-004

Adenocarcinoma

1

I

T2N0M0

M

25

T7-005

Adenocarcinoma

1

II

T3N0M0

M

44

T7-006

Adenocarcinoma

2

II

T3N0M0

M

49

T7-007

Adenocarcinoma

2

II

T3N0M0

M

41

T7-008

Adenocarcinoma

3

II

T3N0M0

M

52

T7-009

Adenocarcinoma

3

II

T4NxM0

M

67

T7-010

Adenocarcinoma

n/a

IIB

n/a

M

46

T7-011

Mucinous Adenocarcinoma

n/a

III

T3N1M0

M

45

T7-012

Mucinous Adenocarcinoma

2

III

T3N1M0

M

42

T7-013

Adenocarcinoma

1

II

T2N1M0

M

77

T7-014

Adenocarcinoma

2

III

T2N1M0

M

66

T7-015

Adenocarcinoma

2

III

T3NxM0

M

61

T7-016

Adenocarcinoma

2

IIIA

T2N1M0

M

38

T7-017

Adenocarcinoma

3

IIIA

T2N1M0

M

68

T7-018

Adenocarcinoma

3

IIIA

T2N1M0

M

50

T7-019

Mucinous Adenocarcinoma

1

IIIA

T2N1M0

F

73

T7-020

Mucinous Adenocarcinoma

1

IIIB

T3N1M0

M

55

T7-021

Adenocarcinoma

n/a

IIIB

T3N1M0

M

54

T7-022

Adenocarcinoma

1

n/a

T4N2M0

M

66

T7-023

Adenocarcinoma

2

n/a

T4N3M0

M

35

T7-024

Mucinous Adenocarcinoma

n/a

IV

T3N1M1

M

26

T7-025

Eosinophynic Granuloma

n/a

n/a

n/a

M

25

T7-026

Adenocarcinoma

2

II

T3N0Mx

M

79

T7-027

Multipolyposis

n/a

n/a

n/a

M

40

T7-028

Lymphoma

n/a

n/a

n/a

M

44

T7-029

non-Hodgkin Lymphoma

n/a

n/a

n/a

M

46

T7-030

Leiomyosarcoma

2

I

T2N0M0

M

65

T7-031

non-Hodgkin Lymphoma

1

IIIB

T3N1M0

M

79

T7-032

Adenocarcinoma

1

I

T2N0M0

F

38

T7-033

Adenocarcinoma

2

n/a

T2N0M0

F

57

T7-034

Adenocarcinoma

1

II

T3N0M0

F

46

T7-035

Adenocarcinoma

n/a

II

T2N0M0

F

67

T7-036

Adenocarcinoma

3

III

T4N3M0

M

43

T7-037

Adenocarcinoma

2

III

T3NxM0

F

63

T7-038

Adenocarcinoma

2

III

T3N1M0

F

59

T7-039

Mucinous Adenocarcinoma

1

III

T3N1M0

F

53

T7-040

Adenocarcinoma

2

IIIA

T2N1M0

F

74

T7-041

Adenocarcinoma

1

IIIA

T2N1M0

F

66

T7-042

Adenocarcinoma

1

IIIB

T3N1M0

F

43

T7-043

Mucinous Adenocarcinoma

1

IIIB

T3N1M0

F

46

T7-044

Adenocarcinoma

3

IV

T3NxM1

F

70

T7-045

Adenocarcinoma

n/a

IV

n/a

F

69

T7-046

Adenocarcinoma

n/a

IV

T3N1M0

F

58

T7-048

non-Hodgkin Lymphoma

n/a

IIIA

T2N1M0

F

32

T7-049

Papillary Adenocarcinoma

2

III

T3N0M0

F

56

T7-050

Papillary Adenocarcinoma

n/a

III

T3NxM0

F

63

 

References:

Saclarides TJ, Szeluga D, Staren ED: Neuroendocrine cancers of the colon and rectum. Results of a ten-year experience. Dis Colon Rectum 37 (7): 635-42, 1994.